Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$93.17
al cierre: Aug 20 EDT
$93.28
0.110.12%
Pre-comercialización: 7:38 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Citigroup Inc ha un obiettivo di prezzo di consenso pari a $89.17, stabilito in base alle ultime valutazioni degli analisti di 20. Le ultime 3 valutazioni degli analisti sono state rilasciate da Oppenheimer, Wells Fargo y Truist Securities il julio 30, 2025, julio 16, 2025 y julio 16, 2025. Con un obiettivo di prezzo medio di $112.67 tra le Oppenheimer, Wells Fargo y Truist Securities, c'è un implicito 20.78% upside per Citigroup Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Oppenheimer
Wells Fargo
Truist Securities
Piper Sandler
Barclays
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Citigroup
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
07/30/2025 | 32.93% | Oppenheimer | $123 → $124 | Maintains | Outperform | |||
07/16/2025 | 23.28% | Wells Fargo | $110 → $115 | Maintains | Overweight | |||
07/16/2025 | 6.13% | Truist Securities | $93 → $99 | Maintains | Buy | |||
07/16/2025 | 11.49% | Piper Sandler | $84 → $104 | Maintains | Overweight | |||
07/16/2025 | 31.86% | Oppenheimer | $107 → $123 | Maintains | Outperform | |||
07/16/2025 | 7.2% | Barclays | $95 → $100 | Maintains | Overweight | |||
07/16/2025 | 1.84% | TD Cowen | $85 → $95 | Maintains | Hold | |||
07/16/2025 | 14.7% | Morgan Stanley | $103 → $107 | Maintains | Overweight | |||
07/15/2025 | -4.59% | UBS | $89 → $89 | Maintains | Neutral | |||
07/09/2025 | -0.3% | Truist Securities | $84 → $93 | Maintains | Buy | |||
07/03/2025 | 10.42% | Morgan Stanley | $94 → $103 | Maintains | Overweight | |||
07/02/2025 | 2.91% | Goldman Sachs | $85 → $96 | Maintains | Buy | |||
07/02/2025 | -17.46% | Evercore ISI Group | $76 → $77 | Maintains | In-Line | |||
06/26/2025 | 7.2% | B of A Securities | $89 → $100 | Maintains | Buy | |||
06/23/2025 | 0.77% | Morgan Stanley | $90 → $94 | Maintains | Overweight | |||
06/10/2025 | -8.88% | Goldman Sachs | $75 → $85 | Maintains | Buy | |||
04/28/2025 | 0.77% | Oppenheimer | $91 → $94 | Maintains | Outperform | |||
04/16/2025 | -16.38% | RBC Capital | $85 → $78 | Maintains | Outperform | |||
04/16/2025 | -1.38% | Keefe, Bruyette & Woods | $96 → $92 | Reiterates | Outperform → Outperform | |||
04/16/2025 | -17.46% | Piper Sandler | $83 → $77 | Reiterates | Overweight → Overweight | |||
04/16/2025 | -15.31% | Truist Securities | $84 → $79 | Maintains | Buy | |||
04/04/2025 | -9.95% | Truist Securities | $85 → $84 | Maintains | Buy | |||
04/03/2025 | -19.06% | JP Morgan | $85.5 → $75.5 | Maintains | Neutral | |||
04/02/2025 | -4.59% | B of A Securities | $90 → $89 | Maintains | Buy | |||
04/01/2025 | -18.53% | Evercore ISI Group | $79 → $76 | Maintains | In-Line | |||
03/19/2025 | -14.24% | Goldman Sachs | $90 → $80 | Maintains | Buy | |||
03/13/2025 | 16.85% | Morgan Stanley | $110 → $109 | Maintains | Overweight | |||
03/10/2025 | -3.52% | B of A Securities | $100 → $90 | Maintains | Buy | |||
02/18/2025 | 7.2% | B of A Securities | $95 → $100 | Maintains | Buy | |||
01/29/2025 | -3.52% | Goldman Sachs | $86 → $90 | Maintains | Buy | |||
01/16/2025 | -8.88% | RBC Capital | $74 → $85 | Maintains | Outperform | |||
01/16/2025 | -6.74% | Argus Research | $72 → $87 | Maintains | Buy | |||
01/16/2025 | 16.85% | Morgan Stanley | $104 → $109 | Maintains | Overweight | |||
01/16/2025 | -15.31% | Evercore ISI Group | $69 → $79 | Maintains | In-Line | |||
01/16/2025 | -7.81% | Goldman Sachs | $77 → $86 | Maintains | Buy | |||
01/16/2025 | -1.38% | Keefe, Bruyette & Woods | $85 → $92 | Maintains | Outperform | |||
01/16/2025 | -11.02% | Piper Sandler | $80 → $83 | Reiterates | Overweight → Overweight | |||
01/07/2025 | 1.84% | B of A Securities | $90 → $95 | Maintains | Buy | |||
01/07/2025 | -8.88% | Truist Securities | — | → $85 | Initiates | → Buy | ||
01/06/2025 | 1.84% | Barclays | $70 → $95 | Upgrade | Equal-Weight → Overweight | |||
01/03/2025 | 17.92% | Wells Fargo | $95 → $110 | Maintains | Overweight | |||
01/03/2025 | -8.88% | Keefe, Bruyette & Woods | $82 → $85 | Maintains | Outperform | |||
01/03/2025 | 9.34% | Oppenheimer | $110 → $102 | Maintains | Outperform | |||
01/02/2025 | -26.03% | Evercore ISI Group | $66 → $69 | Maintains | In-Line | |||
12/06/2024 | -13.17% | Goldman Sachs | $72 → $81 | Maintains | Buy | |||
12/03/2024 | -12.1% | Keefe, Bruyette & Woods | $70 → $82 | Upgrade | Market Perform → Outperform | |||
12/03/2024 | -14.24% | Piper Sandler | $73 → $80 | Maintains | Overweight | |||
12/02/2024 | -3.52% | B of A Securities | $78 → $90 | Maintains | Buy | |||
11/15/2024 | 1.84% | Wells Fargo | $85 → $95 | Maintains | Overweight | |||
11/05/2024 | 14.7% | Oppenheimer | $91 → $107 | Maintains | Outperform | |||
10/16/2024 | -24.96% | Barclays | $63 → $70 | Maintains | Equal-Weight | |||
10/16/2024 | -31.39% | Evercore ISI Group | $63 → $64 | Maintains | In-Line | |||
10/16/2024 | -2.45% | Oppenheimer | $92 → $91 | Maintains | Outperform | |||
10/16/2024 | -12.1% | Morgan Stanley | $86 → $82 | Maintains | Overweight | |||
10/16/2024 | -16.38% | B of A Securities | $77 → $78 | Maintains | Buy | |||
10/02/2024 | -1.38% | Oppenheimer | $87 → $92 | Maintains | Outperform | |||
09/30/2024 | -7.81% | Morgan Stanley | $79 → $86 | Maintains | Overweight | |||
09/11/2024 | -23.89% | Goldman Sachs | $75 → $71 | Maintains | Buy | |||
07/30/2024 | -15.31% | Morgan Stanley | $66 → $79 | Maintains | Overweight | |||
07/15/2024 | -28.18% | BMO Capital | $65 → $67 | Maintains | Market Perform | |||
07/15/2024 | -22.82% | Argus Research | $70 → $72 | Maintains | Buy | |||
07/15/2024 | -21.74% | Piper Sandler | $70 → $73 | Reiterates | Overweight → Overweight | |||
07/15/2024 | -7.81% | Oppenheimer | $85 → $86 | Maintains | Outperform | |||
07/15/2024 | -29.25% | Morgan Stanley | $65 → $66 | Maintains | Overweight | |||
07/03/2024 | -33.54% | Evercore ISI Group | $60 → $62 | Maintains | In-Line | |||
06/20/2024 | -30.32% | Morgan Stanley | $65 → $65 | Maintains | Overweight | |||
06/20/2024 | -29.25% | RBC Capital | $66 → $66 | Reiterates | Outperform → Outperform | |||
06/20/2024 | -26.03% | Keefe, Bruyette & Woods | $66 → $69 | Maintains | Market Perform | |||
06/17/2024 | -29.25% | RBC Capital | $63 → $66 | Maintains | Outperform | |||
04/30/2024 | -7.81% | Oppenheimer | $87 → $86 | Maintains | Outperform | |||
04/15/2024 | -32.46% | BMO Capital | $61 → $63 | Maintains | Market Perform | |||
04/15/2024 | -24.96% | Argus Research | $60 → $70 | Maintains | Buy | |||
04/15/2024 | -24.96% | Piper Sandler | $67 → $70 | Maintains | Overweight | |||
04/15/2024 | -6.74% | Oppenheimer | $88 → $87 | Maintains | Outperform | |||
04/08/2024 | -30.32% | Jefferies | $56 → $65 | Maintains | Hold | |||
04/05/2024 | -29.25% | Keefe, Bruyette & Woods | $54 → $66 | Maintains | Market Perform | |||
04/01/2024 | — | Goldman Sachs | — | Maintains | Buy | |||
04/01/2024 | -14.24% | Wells Fargo | $80 → $80 | Maintains | Overweight | |||
03/28/2024 | -24.96% | HSBC | $61 → $70 | Maintains | Buy | |||
03/25/2024 | -14.24% | Wells Fargo | $70 → $80 | Maintains | Overweight | |||
03/19/2024 | -5.66% | Oppenheimer | $95 → $88 | Maintains | Outperform | |||
03/15/2024 | -27.1% | Goldman Sachs | $55 → $68 | Maintains | Buy | |||
03/14/2024 | -27.1% | Goldman Sachs | $55 → $68 | Upgrade | Neutral → Buy | |||
02/14/2024 | -32.46% | Piper Sandler | $56 → $63 | Upgrade | Neutral → Overweight | |||
01/30/2024 | 1.84% | Oppenheimer | $93 → $95 | Maintains | Outperform | |||
01/30/2024 | -30.32% | Morgan Stanley | $46 → $65 | Upgrade | Underweight → Overweight | |||
01/16/2024 | -0.3% | Oppenheimer | $85 → $93 | Maintains | Outperform | |||
01/16/2024 | -39.97% | Piper Sandler | $53 → $56 | Maintains | Neutral | |||
01/10/2024 | — | BMO Capital | — | Downgrade | Outperform → Market Perform | |||
01/09/2024 | -34.61% | HSBC | → $61 | Upgrade | Hold → Buy | |||
01/03/2024 | -37.82% | Wolfe Research | → $58 | Upgrade | Peer Perform → Outperform | |||
01/02/2024 | -32.46% | Barclays | $59 → $63 | Maintains | Equal-Weight | |||
12/19/2023 | -44.26% | Goldman Sachs | $47 → $52 | Maintains | Neutral | |||
12/01/2023 | -49.62% | Goldman Sachs | $41 → $47 | Maintains | Neutral | |||
11/16/2023 | -8.88% | Oppenheimer | $82 → $85 | Maintains | Outperform | |||
10/16/2023 | -51.76% | Piper Sandler | $47 → $45 | Maintains | Neutral | |||
10/16/2023 | -29.25% | BMO Capital | $61 → $66 | Maintains | Outperform | |||
10/16/2023 | -12.1% | Oppenheimer | $81 → $82 | Maintains | Outperform | |||
10/03/2023 | -53.9% | Morgan Stanley | $45 → $43 | Maintains | Underweight | |||
10/02/2023 | -56.05% | Goldman Sachs | $47 → $41 | Maintains | Neutral |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Citigroup (C)?
El último precio objetivo de Citigroup (NYSE:C) fue comunicado por Oppenheimer el julio 30, 2025. La firma de analistas fijó un precio objetivo para $124.00 que espera C a rise dentro de 12 meses (un posible 32.93% upside). 58 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Citigroup (C)?
La última calificación de analistas para Citigroup (NYSE:C) fue proporcionada por Oppenheimer, y Citigroup mantuvo su outperform calificación.
¿Cuándo se produjo la última revisión al alza de Citigroup (C)?
La última revisión al alza de Citigroup Inc se produjo en enero 6, 2025, cuando Barclays elevó su precio objetivo a $95. Barclays anteriormente tenía an equal-weight para Citigroup Inc.
¿Cuándo fue la última revisión a la baja de Citigroup (C)?
La última revisión a la baja de Citigroup Inc se produjo en enero 10, 2024, cuando BMO Capital cambió su precio objetivo de N/A a N/A para Citigroup Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Citigroup (C)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Citigroup, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Citigroup se registró el julio 30, 2025, por lo que la próxima calificación estará disponible en torno al julio 30, 2026.
¿Es correcta la calificación de los analistas sobre Citigroup (C)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Citigroup (C) fue un mantuvo con un precio objetivo de $123.00 a $124.00. El precio actual al que cotiza Citigroup (C) es de $93.28, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.